Showing results (141-150 of 177) with videos related to
Sort By:
Pageof 18
Journal of Clinical Pathology|April 18, 2000
Danish type gelsolin related amyloidosis: 654G-T mutation is associated with a disease pathogenetically and clinically similar to that caused by the 654G-A mutation (familial amyloidosis of the Finnish type)C P Maury, M Liljeström, G Boysen, et al.Chest|April 1, 1988
Effects of expiratory flow resistance on inspiratory work of breathingM J Banner, J B Downs, R R Kirby, et al.Stroke|October 1, 1988
Danish very-low-dose aspirin after carotid endarterectomy trialG Boysen, P S Sørensen, M Juhler, et al.Stroke|November 1, 1988
Stroke incidence and risk factors for stroke in Copenhagen, DenmarkG Boysen, J Nyboe, M Appleyard, et al.Nature Genetics|October 1, 1992
Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187A de la Chapelle, R Tolvanen, G Boysen, et al.Chest|October 1, 1977
Prospective evaluation for pneumonectomy using the 99mtechnetium quantitative perfusion lung scanP G Boysen, A J Block, G N Olsen, et al.Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 31, 1998
Oral toxicity and carcinogenicity studies of sucrose acetate isobutyrate (SAIB) in the Fischer 344 rat and B6C3F1 mouseK M Mackenzie, P J Tisdel, R L Hall, et al.Der Pathologe|August 30, 2008
[Von-Hippel-Lindau gene mutation types. Association of gene expression signatures in clear cell renal cell carcinoma]V D Luu, B Fischer, A von Teichman, et al.Environmental and Molecular Mutagenesis|December 12, 2018
Understanding the importance of low-molecular weight (ethylene oxide- and propylene oxide-induced) DNA adducts and mutations in risk assessment: Insights from 15 years of research and collaborative discussionsL H Pottenger, G Boysen, K Brown, et al.Archives of Internal Medicine|July 29, 1998
Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation StudyA L Gulløv, B G Koefoed, P Petersen, et al.Pageof 18